Company Filing History:
1 out of 1 
1 out of 1,248 
1 out of 1 Years Active: 2001-2003
Title: The Innovations of Jeremy Mark Wells
Introduction
Jeremy Mark Wells is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in vaccine development and the delivery of biologically active polypeptides. With a total of 4 patents to his name, Wells has established himself as a key figure in his area of expertise.
Latest Patents
One of his latest patents is for a Clostridium perfringens vaccine. This invention relates to detoxified immunogenic derivatives of β-toxin or an immunogenic fragment thereof. These derivatives carry a mutation in the β-toxin amino acid sequence, which is not found in the wild-type β-toxin amino acid sequence. The invention also encompasses genes encoding such β-toxins, as well as expression systems that express these β-toxins. Additionally, it includes bacterial expression systems that express a native β-toxin and vaccines based on detoxified immunogenic derivatives of β-toxin, along with methods for their preparation. Another significant patent involves the delivery of biologically active polypeptides. This patent describes a method for delivering biologically active polypeptides and/or antigens by administering a non-invasive or non-pathogenic bacterium that expresses one or more antigens or polypeptides. This bacterium can be included in delivery systems or pharmaceutical formulations.
Career Highlights
Throughout his career, Wells has worked with various companies, including Microdial Technics Ltd. His work has focused on innovative solutions in the biotechnology sector, contributing to advancements in vaccine technology and therapeutic delivery systems.
Collaborations
Wells has collaborated with notable individuals in his field, including Lothar Steidler and Erik R Remaut. These collaborations have further enhanced his research and development efforts.
Conclusion
Jeremy Mark Wells is a distinguished inventor whose work in vaccine development and biologically active polypeptide delivery has made a significant impact in biotechnology. His innovative patents and collaborations reflect his commitment to advancing medical science.